Luncheons

Regulatory Strategy: Guiding Your Innovative Product to Success

Conference room: Forum 1

The United States is the undisputed world leader when it comes to medical biotechnology. Receiving FDA approval for a therapy is considered a milestone in a company's development and a blueprint for growth in other markets. Likewise, providers of innovative services seek access to the world's largest healthcare market. Almost every company sooner or later faces the question of how to approach this market. Together with our experts, we will take a concise and practical look at the challenges and trends in US business. We will explore what really matters. Come and join the discussion!

Impulse lecture

Dr. Angela Vogt-Eisele

Dr. Angela Vogt-Eisele

PharmaLex

Dr. Zaklina Buljovcic

Dr. Zaklina Buljovcic

PharmaLex